Pediatric Chronic Kidney Disease.
Panzarino V, Lesser J, Cassani FA.
Adv Pediatr. 2022 Aug;69(1):123-132. doi: 10.1016/j.yapd.2022.03.008.
Systemic Inflammatory Response Index (SIRI) is associated with all-cause mortality and cardiovascular mortality in population with chronic kidney disease: evidence from NHANES (2001-2018).
Gu L, Xia Z, Qing B, Wang W, Chen H, Wang J, Chen Y, Gai Z, Hu R, Yuan Y.
Front Immunol. 2024 Mar 15;15:1338025. doi: 10.3389/fimmu.2024.1338025. eCollection 2024.
The impact of chronic kidney disease Stages 3-5 on pregnancy outcomes.
Wiles K, Webster P, Seed PT, Bennett-Richards K, Bramham K, Brunskill N, Carr S, Hall M, Khan R, Nelson-Piercy C, Webster LM, Chappell LC, Lightstone L.
Nephrol Dial Transplant. 2021 Nov 9;36(11):2008-2017. doi: 10.1093/ndt/gfaa247.
European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4-G5D.
Evenepoel P, Cunningham J, Ferrari S, Haarhaus M, Javaid MK, Lafage-Proust MH, Prieto-Alhambra D, Torres PU, Cannata-Andia J; European Renal Osteodystrophy (EUROD) workgroup, an initiative of the CKD-MBD working group of the ERA-EDTA, and the committee of Scientific Advisors and National Societies of the IOF.
Nephrol Dial Transplant. 2021 Jan 1;36(1):42-59. doi: 10.1093/ndt/gfaa192.
Prevalence and incidence of chronic kidney disease stage 3-5 - results from KidDiCo.
Kampmann JD, Heaf JG, Mogensen CB, Mickley H, Wolff DL, Brandt F.
BMC Nephrol. 2023 Jan 19;24(1):17. doi: 10.1186/s12882-023-03056-x.
Copper homeostasis in chronic kidney disease and its crosstalk with ferroptosis.
Jiayi H, Ziyuan T, Tianhua X, Mingyu Z, Yutong M, Jingyu W, Hongli Z, Li S.
Pharmacol Res. 2024 Apr;202:107139. doi: 10.1016/j.phrs.2024.107139. Epub 2024 Mar 12.
Stage effect of chronic kidney disease in erectile function.
Costa MR, Ponciano VC, Costa TR, Gomes CP, de Oliveira EC.
Int Braz J Urol. 2018 Jan-Feb;44(1):132-140. doi: 10.1590/S1677-5538.IBJU.2017.0228.
Chronic Kidney Disease and Pregnancy.
Hladunewich MA.
Semin Nephrol. 2017 Jul;37(4):337-346. doi: 10.1016/j.semnephrol.2017.05.005.
[Frailty in chronic kidney disease].
Grupp C.
Z Gerontol Geriatr. 2021 May;54(3):217-222. doi: 10.1007/s00391-021-01860-4. Epub 2021 Feb 25.
Hypolipidemic Therapy and Chronic Kidney Disease: Effects on Cardiovascular Risks and Renal Dysfunction.
Aitbaev KA, Murkamilov IT, Fomin VV.
Kardiologiia. 2019 Mar 8;59(2):79-87. doi: 10.18087/cardio.2019.2.10231.
